Status:

UNKNOWN

Correlation of Polymorphisms of Lipoprotein Lipase (LpL) and Apolipoprotein E (Apo E) With Lipid Profile of Children With Acute Lymphoblastic Eukaemia During Therapy With L - Asparaginase.

Lead Sponsor:

Aristotle University Of Thessaloniki

Conditions:

Acute Lymphoblastic Leukemia

Eligibility:

All Genders

Up to 16 years

Brief Summary

Haematological malignancies constitute the most common neoplastic disease in child population, with acute leukemia occupying the number one spot with a percentage of 32.8%. In children, leukaemia is p...

Detailed Description

Introduction Malignancies during childhood constitute the 2nd cause of death, following injuries worldwide. According to epidemiological data, 300,000 new cases of neoplasia present themselves every ...

Eligibility Criteria

Inclusion

  • Inclusion Criteria:
  • Children and adolescents newly diagnosed with acute lymphoblastic leukaemia. A complete personal and family history will be recorded for each participant from every group with particular emphasis on the presence of dyslipidaemia, early cardiovascular disease or cerebrovascular accident in the individual or in the family. A thorough clinical examination will be performed and the vital signs, blood pressure, weight (kg), height (m) and a Body/Mass Index (BMI) will be recorded and calculate.
  • The Exclusion criteria are the following:
  • Thyroid Disorder (Abnormal thyroid function)
  • Familial Hypercholesterolemia
  • High Body/ Mass Index (BMI)
  • Administration of corticosteroids some time during the past 2 weeks before diagnosis
  • Administration of total parenteral nutrition before the diagnosis
  • Administration of plasma before the diagnosis
  • Changes or variation of the parameters under study before the start of treatment and the 11th day (before the start of asparagine administration).

Exclusion

    Key Trial Info

    Start Date :

    September 1 2019

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ESTIMATED

    End Date :

    August 31 2022

    Estimated Enrollment :

    90 Patients enrolled

    Trial Details

    Trial ID

    NCT04364451

    Start Date

    September 1 2019

    End Date

    August 31 2022

    Last Update

    April 28 2020

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Paediatric and Adolescent Haematology-Oncology Unit, 2nd Department of Paediatrics, Aristotle University of Thessaloniki (AUTH), University General Hospital AHEPA

    Thessaloniki, Greece, 54636